Invention Grant
- Patent Title: Ion channel modulating activity I
- Patent Title (中): 离子通道调节活性
-
Application No.: US12689909Application Date: 2010-01-19
-
Publication No.: US08207219B2Publication Date: 2012-06-26
- Inventor: David Fedida , Gregory N. Beatch , Alan M. Ezrin , Peter M. R. Orth , Christian Hesketh
- Applicant: David Fedida , Gregory N. Beatch , Alan M. Ezrin , Peter M. R. Orth , Christian Hesketh
- Applicant Address: CA Vancouver, B.C.
- Assignee: Cardiome Pharma Corp.
- Current Assignee: Cardiome Pharma Corp.
- Current Assignee Address: CA Vancouver, B.C.
- Agency: Cooley LLP
- Main IPC: A61K31/40
- IPC: A61K31/40

Abstract:
Methods, compositions, dosing regimes, and routes of administration for the treatment or prevention of arrhythmias. In these methods, early afterdepolarizations and prolongation of QT interval may be reduced or eliminated by administering ion channel modulating compounds to a subject in need thereof. The ion channel modulating compounds may be cycloalkylamine ether compounds, particularly cyclohexylamine ether compounds. Also described are compositions of ion channel modulating compounds and drugs which induce early afterdepolarizations, prolongation of QT interval and/or Torsades de Pointes.
Public/Granted literature
- US20100120890A1 ION CHANNEL MODULATING ACTIVITY I Public/Granted day:2010-05-13
Information query